-OM: - most common disease of children,
- leading cause of hearing loss in children, and the
- most frequent indication for antimicrobial/surgical Rx in children. -costs of therapy over $1 billion expended each year US
more than I million operative procedures per yr in US
-85% of children experience at least one episode of OM
-causes of OM are multiple
-predisposing factors are:
-young age, maleness, bottle feeding, crowded living, heredity,
allergy, socioeconomic status, smoking by mother,
parental history of otitis media, viral infections at home,
-associated conditions (cleft palate, immunodef. ciliary dyskinesia,Down syndrome, &CF).
NB: less common in black (due to differences in size & angulation of ET
NB: birth wt not significant & breast feeding protective only until stopped
BACKGROUND
Definitions
-OM: generic term for inflam’n within middle ear cleft behind intact TM
-Middle ear effusion (MEE) : generic term for liquid in middle ear cleft
regardless of etiology.
-Acute otitis media (AOM) : symptoms & signs of acute infection
(middle ear effusion with fever; pain; red, bulging TM).
-Chronic otitis media with effusion (OME) or "glue ear":
( <=>chronic secretory otitis media, chronic serous otitis media),
(middle ear effusion without pain, redness, or bulging TM)
- Others: chronic suppurative otitis media with:
-permanent perforation of TM or
-cholesteatoma.
Clinical and functional anatomy
-middle ear cleft: continuous space from nasopharyngeal orifice of ET to
the furthermost mastoid air cells.
-three main segments are :
-ET;
-middle ear (tympanum);
-air cells of the mastoid, petrosa, and related areas.
-mucosal lining of middle ear cleft varies from
-thick,ciliated, respir. epth elium of ET & anterior tympanum to
-thin, featureless cuboidal epithelium in mastoid cells.
-middle ears of pts with OM=> hyperplasia & Ý in goblet cells Sade ‘66 NB: thought to predispose to formation of effusion.
-Tympanic mucous blanket is swept twd NPx by action of ciliated epth =>secretions/particles are cleared from mid.ear into NPx via ET
-ET:
-normally closed to protect middle ear from entry of unwanted material
-opens with swallowing & other maneuvers due to TVP m contraction
=>equilibration of pressure in middle ear to ambient pressure
-three classic functions:
aeration, clearance, and protection of the middle ear.
TYPES
*(A) OTITIS MEDIA
PATHOPHYSIOLOGY
-historically linked with abnormalities of eustachian tube function.
-Hypotheses:
-early studies suggested obstruction(underaeration) of ET was the prob
-new work=>suggests failure of protection (abN patent or compliant ET) => bacteria enter ME
=> AOM
NB: Tubal obstruction with failure of clearance may be 2’ry rather than primary processes
* (B) ACUTE OTITIS MEDIA
-a bacterial disorder (majority)
Streptococcus pneumoniae
Haemophilus influenzae
Branhamella catarrhalis
Streptococcus pyogenes
Staphylococcus aureus
Staphylococcus epidermidis
-viruses in 20% of early cases,
(in some cases as sole agent, but more often with bacteria).
-Pathogenic bacteria subsequently are found in nasopharynges of 97% of patients with AOM,
with correspondence to organisms in middle ear effusion in 69% (Howie and Ploussard, 1972).
-Ad’s of children with recurrent AOM contains pathogenic bacteria in clinically significant amnts
-Ad’s (pharyngeal tonsil) forms uppermost part of Waldeyer’s ring
-is covered by resp epith rich in goblet cells
-numerous surface folds
-abundant lymphocytes are found within, esp. on crests of folds.
-is fully developed at 7th month, & increases in size until year 5
-nasal mucociliary blanket carries material posteriorly across ads.
-regarded as a B-cell organ.
-There is a significant age correlation with middle-ear pathogens in the
nasopharynges of clinically disease-free children;
-57% of under-2-year-old group were culture positive VS
-40% of 2 to 15-year-old children.
-Thus=> adenoid in AOM is a bacterial reservoir in nasopharynx.
- route of entry of NP bugs into middle ear is via reflux from ET:
-during swallowing (seen radiographically Bluestone 1972).
-facl’td by nose blowing & closed-nose swallowing,(Toynbee mnv)
-aspiration into middle ear due to negative pressure (eg sniffing)
-patulous eustachian tubes
-young children have shorter, straighter, more compliant ET’s
- adenoid is elevated by soft palate during swallowing,
\ when big may obstruct post choanae & Þ Ý NP P Þ reflux.
-Ad’s size in children with OM did not differ from control either radiographically (Hibbert 82) or
by weight (Gerwat, 1975)
-no difference in recurrence of effusion in kids with large vs small ads
-it is unnecessary to postulate ET obstruction as a necessary precedent for AOM to occur
-never been shown that adenoid physically obstructs the ET; in fact, has been shown it doesn’t.
-Study: Honjo (1988) studied 52 OME kids & compared ET fnct’n in pts with a large adenoid (which appeared to obstruct ET on scope )
vs
pts with a clearly open tube.
Result Þ No difference in opening pressure or in positive pressure
equalization was noted between the two groups.
Þ No diff in ET ventilation function pre- & after adnoidectomy
Takahashi (1987) studied 10 adults with OME using thin catheter
Þ site of ET obstr’n is at distal part of cartilag tube (5-15 mm from end orifice),
rather than at the orifice proper.
-Improvement in ET, does occur after adenoidectomy (Bluestone 1972)
*(C) OTITIS MEDIA WITH EFFUSION
- ET dysfuntion nearly always found in OME
-ligation of ET in animals Þ MEE
-2 categories of OME:
(1) persistent MEE following an acute effusion
(2) secretary otitis media.
-Pathophysiology:
- failure of the middle ear clearance mechanism.
-Factors involved include:
-ciliary dysfunction, mucosal edema & hyperplasia,
viscosity of secretions, middle ear/NP pressure gradient.
-Barotrauma: occurs when mid ear P becomes rapidly < atm P
Þ a clear, watery transudate
-Seen sporadically due to viral infection
-Cleft palate (nearly a universal finding)
(Mech: defect is related to function of TVP m, which lacks its usual insertion into soft
palate,Þ unable to open ET properly on swallowing Þ functional obstruction )
-Histopathology
-temporal bone in OM shows:
-vascular dilt’n & prolif’n, mononucl cells,
-epith thickening & metaplasia; gland formtn, edema & exudation
Sequelae
-adverse effects of OME on hearing & development
-otologic sequelae: permanent perforation, CSOM, tympanosclerosis, adhesive OM,
ossicular necrosis, retraction pockets cholesteatoma, & SNHL
DIAGNOSIS
Hx: -Older children Þ earache,
-InfantsÞ fussy, sleep poorly, and pull at affected ear, fever
-may be completely asymptomatic.
Otoscopy
1. AOM
-redness and bulging TM
-as effusion develops, drum mobility decreases
-severe cases no landmarks may be visible
-if process continuesÞ necrosis of TM occurs Þ perforation.
NB: -massive necrosis of drumhead is now rare
-necrotizing streptococcal infct’n Þ permanent perforation.
-pneumatic otoscope: pressures of 1-2mm H20 Þ detectable motion
-clinical variants of AOM:
- Myringitis: inflammation of TM without MEE
- Bullous myringitis:
- adults and children
- most cases associated with same pathobacteria as AOM
some with Mycoplasma pneumoniae
-pain is outstanding feature, not relieved by opening bullae.
2. OME
-retracted, hypomobile/immobile TM
-dark, fluid-filled drum (obscurring vision of incus long process)
Audiometry
- moderate conductive hearing loss
-studies show variable range of hearing loss in OM, with AC thresholds averaging 27.5 dB
-hearing loss due to MEE is a principal indication for surgical treatment
TREATMENT
1. Acute otitis media
a. Antimicrobial therapy
-important to consider using B lactamase-resistant agents as first line
-duration of therapy: 10-day course
b. Adjunct medical therapy
-nasal decongestant open the airway, may be used for short periods,but prolonged use may worsen rather than improve airway b/c of rebound.
c. Tympanocentesis
-Knowledge of specific organism is important for:
(1) premature newborns
(2) immunocompromised patients
(3) patients with progression of Sx & signs while on Rx
(4) cases with intracranial infection
(5) research subjects
-method: - 18-gauge spinal needle attached to a 1-ml tuberculin syringe.
- no anesthetic is necessary
- needle inserted into anteroinferior quadrant of TM
d. Myringotomy
- AOM myringotomy, has proven to be of limited value.
-promptly relieves severe pain
-adds little to remission of inf’n or clearance of MEE.Englehard1989
-report of van Buchem (1981) has been cited as showed:
Þ no difference in outcome with AOM whether A/B, myringotomy, both, or neither used.
(NB:large amt of methodologic flaws)
e. Follow-up
-impt: i. to assure infection is responding to AB’s
ii. to determine that the MEE has resolved
iii. important to exclude meningitis
-Therefore, a 3-day check is performed to determine response
a 2-week check is to determine if MEE has cleared
-Natural history of AOM Þ approx 1/2 ears will have cleared by 2/52
-little evidence to suggest prolonged/repeated therapy is useful
-if TM has ruptured, indicating a severe episode,
Þ continue AB’s until drainage has ceased & TM has sealed.
f. Recurrence & Prophylaxis
-Perrin (1974) & Varsano (1985)Þ sulfisoxazole chemoprevention of AOM -Casselbrant, 1990 Þ daily dose of amoxicillin, 20 mg/kg, for 3-6 mths
-Indication for prophylaxis is 3 or more episodes of AOM in 6/12 period.
-If develop recurrent AOM while on prophylaxis Þ Sx.
-Adenoidectomy should be an effective preventive:
-San Antonio trial (Gates 1987), number of episodes of AOM in
2 adenoidectomy gps did not differ from 2 nonadenoidectomy gps
g. Complications
see mastoiditis compln notes
2. Otitis media with effusion
a. Antimicrobial therapy
-MEE is known to contain viable, pathogenic bacteria (Liu et al., 1975).
\ Antimicrobial therapy is logical
-kids with asymptomatic OME discovered by screeningÞ recomm’d.
-followed by > 1-month observation period.
-If improved Þ second course or additional observation
-If no change at I month Þ Sx
b. Antihistamines and decongestants
-no routine use of decongestants in OME ( study by Cantekin 1983)
-steroid Rx of OME is experimental but worthy of continued study.
c. Middle ear inflation
- ET cathetrz’n (Politzer's maneuver) or autoinflation (Toynbee's mnvr)
Þ not generally used.
- Transiently good, but long-term net effect bad
Reason: it worsens the (-’ve) middle ear P pressure b/c the excess air injected into middle ear
passes out the ET, & the O2 remaining is absorbed through middle ear mucosa
-Important to remember gas in middle ear differs substantially from air, being hypercapnic and hypoxic, with gas tension values similar to arterial blood (Segal et al., 1983).
-Ex-vacuo theory : O2 in mid ear is continually absorbed, until replaced
by the ingress of nasopharyngeal air with swallowing.
Surgical therapy
-Surgical therapy does not cure patients with OME, but substantially reduces morbidity when
medical therapy has failed.
-OME & hearing loss persisting > 90-120 days with adequate A/B Rx Þ Sx is recommended.
-The time criterion is tempered by season.
-In Autumn Sx > Spring b/c of higher chance of URTI
-Types of procedures:
-Myringotomy +/- tubes, adenoidectomy +/- tonsillectomy
NB: tonsillectomy has no additional effect on MEE over adenoidectomy alone in cases of
OME (Maw, 1983)
-Myringotomy and suction alone:
- results not effective (Gates 1985; Mandel 1989).
-Tympanostomy tubes.
- introduced by Armstrong in 1954
Þ improved hearing & less AOM
- complications of tubes Þ purulent d/c, recurrent effusion, permanent perf’n,
(short-term tubes app 1%)( up to 5% longer term, bigger diam tubes)
-Long Tshaped tubes introduced by Goode (1973).
-Short have retention times of < year VS T-shaped tubes for years
-Experimental evidence Þ mucosal hyperplasia of tympanum revert to
more normal condition with aeration (Sade, 1966).
Technical considerations.
-Antibiotic drops often used after TT insertion. These have not been
associated with SNHL in humans (but have in experimental animals),
b/c of diff’s in anatomy of RW niche & membrane (Morizono, 1990).
Adenoidectomy. recent studies have confirmed its effectiveness
(Gates 1987; Maw, 1983; Paradise 1990).
Rationale for adenoidectomy.
-1st chief rationale is enlargement Þ nasal obstructn & mouth breathing.
-removal should lessen ET reflux
-removal for OM on size alone, has little scientific basis b/c ad & T enlargement results from
clonal expansion of immunocompetent cells (Fujiyoshi et al., 1989).\ large ad’s may be more
immunocompetent than small ad’s b/c chronic infection is associated with cellular depletion (Bernstein, 1990).
-3 separate studies (Gates 1987; Maw, 1985; Paradise 1990)
Þ effect of adenoidectomy on OM is independent of size.
-2nd classic rationale is improvement in ET function.
-In children with hypercompliant ET’s, adenoidectomy may Ý reflux.
-3rd and most current rationale is removal of chronically infected ad’s
to eliminate a nasopharyngea source of infection (Gates 1988).
Efficacy
-principal studies cited as showing a lack of effect of adenoidectomy are
Þ (Roydhouse 1980), FiellauNikolajsen 1983), Widemar 1985).
-studies demonstrating a significant effect from adenoidectomy are
Þ Maw (1983), Gates 1987), and Paradise 1990).
Technical considerations
-goal of adenoidectomy is complete removal of midline adenoid pad Þ smooth reepithelialization
of the nasopharynx.
-must avoid direct injury to torus tubarius ( Rosenmuller's fossa) that might Þ stenosis.
-most common complication of adenoidectomy is postop bleeding.
- 0.4% require operative treatment for bleeding (esp 1st 6hrs postop)
-Transient VPI may occur after R/O large ads but resolves in most
(most cases of postop VPI are due to undetected submuc cleft pal )
-occult submuc cleft is more obvious on post than ant surface of palate -it is clear that no major systemic immunologic deficiencies result from Ts & As (Siegel, 1984).
Bibliography:
Cummings, C. Otolaryngology. chapter 156
Gates Current Therapeutics
Scott Brown, , Otolaryngology
Schucknect, Pathology of the Ear